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In his letter, Kalman 1 has raised some interesting points in response to our recent publication of yogurt augmenting total and central fat loss secondary to energy. However, the concern regarding compliance as a confounding variable appears to be unfounded. As indicated in the article, 'all subjects maintained complete diet diaries, and compliance was assessed by weekly subject interview and review of the diet diary and product return (analogous to pill counts)'. To expand upon this, subjects were judged to be compliant only if their diet diaries indicated they maintained a total calcium intake of r600 mg/day exclusive of the yogurt or gelatin desert, consumed 80-100% of the product provided (based on product return) and maintained an energy intake within 200 kcal of the daily energy prescription. Using these criteria, 13 of the 18 subjects on the yogurt diet and 10 of the 16 subjects on the control diet met all criteria for compliance. Separate analysis of the compliant subjects yielded comparable data to that found in the analysis of all subjects completing the trial, although the statistical significance achieved was stronger in the compliant group. With regard to the macronutrient, calcium and energy intakes achieved, this data is indeed provided in this paper and summarized in Table 2 . However, to reiterate this data, subjects in both groups achieved a diet that contained 30% of energy from fat, 18% from protein and 52% from carbohydrate. The actual calcium intakes achieved (also shown in Table 2 ) were 495728 mg/day for the control group and 1077722 mg/day for the yogurt group, and the actual energy intake achieved was 1303 and 1437 kcal/day for the control and yogurt groups, respectively. Thus, the targeted calcium intakes were achieved, and the study was not confounded by an altered macronutrient pattern.
The upcoming publication of Bowen et al 2 appears to stand in contrast with our findings. However, that work utilized a much higher level of protein intake (34 energy %/protein vs 18% in our study) making a direct comparison difficult, as higher protein intakes have been shown in some studies to be associated with greater weight loss. Indeed, the weight loss found in the Bowen study was approximately twice that found in the control group in our study (À9.7 vs À4.99 kg). At this higher rate of weight loss, the ability of a high calcium or high dairy diet to elicit additional increments of fat mobilization may be limited. Further, the baseline calcium intakes in the Bowen study were considerably higher (899 and 787 mg/day for men and women, respectively, assigned to the dairy protein diet, and 935 and 737 mg/day for those assigned to the mixed protein diet) than in our clinical trials, 1, 3 in which we have recruited subjects with prestudy calcium intakes of o600 mg/day to ensure that we were studying the effects of correcting suboptimal intakes rather than supplementing adequate intakes. This issue of studying individuals whose baseline intake is significantly below optimal levels may be especially important during short-term trials. Finally, Mr Kalman is correct regarding my patents. Protection of the intellectual property produced by our efforts against inappropriate and/or unauthorized commercial use is a well-known and time-honored option used throughout the biomedical community. My patents and patent applications are well known and are a matter of public record (from which Kalman obtained them), and no attempt has ever been made to obscure their presence or my interest in them.
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